Bart A. Westerman

6.9k citations

52 papers · 1.3k indexed · h-index 21

Impact in

Genetics top 5%
- Glioma Diagnosis and Treatment
- Genetic Syndromes and Imprinting
Cancer Research top 10%
- MicroRNA in disease regulation

Papers in ⓘ

Molecular Biology 30
- Epigenetics and DNA Methylation 9
- Melanoma and MAPK Pathways 4
- RNA modifications and cancer 4
Genetics 13
- Glioma Diagnosis and Treatment 12
- Genetic Syndromes and Imprinting 5

Co-authors: Cees B.M. Oudejans (14 shared papers)Georgi K. Kanev (5 shared papers)Chris de Graaf (4 shared papers)Albert J. Kooistra (4 shared papers)Iwan J. P. de Esch (4 shared papers)Inge J. van Wijk (6 shared papers)Thomas Würdinger (7 shared papers)Ankie Poutsma (7 shared papers)
Journals: Neuro-Oncology Advances (4 papers)The International Journal of Biological Markers (2 papers)Drug Resistance Updates (2 papers)Genomics (2 papers)Molecular Cancer Therapeutics (2 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Bart A. Westerman

50 papers receiving 1.2k citations

Peers

Countries citing papers authored by Bart A. Westerman

Since Specialization

Citations

This map shows the geographic impact of Bart A. Westerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart A. Westerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart A. Westerman more than expected).

Fields of papers citing papers by Bart A. Westerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart A. Westerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart A. Westerman. The network helps show where Bart A. Westerman may publish in the future.

Co-authors

The 25 scholars most cited alongside Bart A. Westerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bart A. Westerman Line = papers co-authored together Bart A. Westerman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	ZNF423 Is Critically Required for Retinoic Acid-Induced Differentiation and Is a Marker of Neuroblastoma Outcome Cancer Cell ·Sidong Huang, Jamila Laoukili, Mirjam T. Epping, Jan Köster, Michael Hölzel, Bart A. Westerman, Wouter Nijkamp, Akiko Hata, Shahab Asgharzadeh, Robert C. Seeger, Rogier Versteeg, Roderick L. Beijersbergen, René Bernards	2009	112
2	The Landscape of Atypical and Eukaryotic Protein Kinases Trends in Pharmacological Sciences ·Georgi K. Kanev, Chris de Graaf, Iwan J. P. de Esch, Rob Leurs, Thomas Würdinger, Bart A. Westerman, Albert J. Kooistra	2019	95
3	KLIFS: an overhaul after the first 5 years of supporting kinase research Nucleic Acids Research ·Georgi K. Kanev, Chris de Graaf, Bart A. Westerman, Iwan J. P. de Esch, Albert J. Kooistra	2020	94
4	Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer Journal of Clinical Investigation ·Karim Nacerddine, Jean-Bernard Beaudry, Vasudeva Ginjala, Bart A. Westerman, Francesca Mattiroli, Ji-Ying Song, Henk G. van der Poel, Olga Balagué, Colin E.J. Pritchard, Paulien Cornelissen‐Steijger, John Zevenhoven, Ellen Tanger, Titia K. Sixma, Shridar Ganesan, Maarten van Lohuizen	2012	93
5	p120-catenin-dependent collective brain infiltration by glioma cell networks Nature Cell Biology ·Pavlo G. Gritsenko, Nader Atlasy, Cindy E. Dieteren, Anna C. Navis, Jan-Hendrik Venhuizen, Cornelia Veelken, Dirk Schubert, Amparo Acker‐Palmer, Bart A. Westerman, Thomas Würdinger, William P. J. Leenders, Pieter Wesseling, Hendrik G. Stunnenberg, Peter Friedl	2020	81
6	The parent-of-origin effect of 10q22 in pre-eclamptic females coincides with two regions clustered for genes with down-regulated expression in androgenetic placentas Molecular Human Reproduction ·Cees B.M. Oudejans, Joyce Mulders, Augusta M.A. Lachmeijer, Marie van Dijk, Andrea A.M. Könst, Bart A. Westerman, Inge J. van Wijk, Peter A. J. Leegwater, Hidenori Kato, Takao Matsuda, Norio Wake, Gustaaf Dekker, Gerard Pals, Leo P. ten Kate, Marinus A. Blankenstein	2004	71
7	The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures BMC Cancer ·Ravi S. Narayan, Carlos Alexandre Fedrigo, Eelke Brands, Rogier Dik, Lukas J.A. Stalpers, Brigitta G. Baumert, Ben J. Slotman, Bart A. Westerman, Godefridus J. Peters, Peter Sminia	2017	53
8	Detection of Chromosome 21-encoded mRNA of Placental Origin in Maternal Plasma Clinical Chemistry ·Cees B.M. Oudejans, Attie T. J. J. Go, Allerdien Visser, Monique A. M. Mulders, Bart A. Westerman, Marinus A. Blankenstein, J. M. G. van Vugt	2003	51
9	Bmi1 Is Required for Hedgehog Pathway-Driven Medulloblastoma Expansion Neoplasia ·Lowell Evan Michael, Bart A. Westerman, Alexandre N. Ermilov, Aiqin Wang, Jennifer Ferris, Jianhong Liu, Marleen Blom, David W. Ellison, Maarten van Lohuizen, Andrzej A. Dlugosz	2008	50
10	Circulating trophoblast in maternal blood Prenatal Diagnosis ·Cees B.M. Oudejans, May Lee Tjoa, Bart A. Westerman, Monique A. M. Mulders, Inge J. van Wijk, J. M. G. van Vugt	2003	47
11	Explaining Blood–Brain Barrier Permeability of Small Molecules by Integrated Analysis of Different Transport Mechanisms Journal of Medicinal Chemistry ·Fleur M.G. Cornelissen, Greta Markert, Ghislaine Deutsch, Maria Antonara, Noa Faaij, Imke H. Bartelink, David P. Noske, W. Peter Vandertop, Andreas Bender, Bart A. Westerman	2023	43
12	Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features. PubMed ·Bart A. Westerman, Sari Neijenhuis, Ankie Poutsma, Renske D.M. Steenbergen, R.H.J. Breuer, Monique Egging, Inge J. van Wijk, Cees B.M. Oudejans	2002	41
13	Allelic IGF2R Repression Does Not Correlate with Expression of Antisense RNA in Human Extraembryonic Tissues Genomics ·Cees B.M. Oudejans, Bart A. Westerman, Diana Wouters, Sascha Gooyer, Peter A. J. Leegwater, Inge J. van Wijk, Frank Sleutels	2001	38
14	The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation Drug Resistance Updates ·Hamza Saleem, U. Kulsoom Abdul, Aslι Küçükosmanoğlu, Megan Houweling, Fleur M.G. Cornelissen, Dieter Henrik Heiland, Monika E. Hegi, Mathilde C.M. Kouwenhoven, David Bailey, Tom Würdinger, Bart A. Westerman	2019	36
15	Cross-Tissue Transcriptomic Analysis of Human Secondary Lymphoid Organ-Residing ILC3s Reveals a Quiescent State in the Absence of Inflammation Cell Reports ·Yotam E. Bar‐Ephraïm, Ferry Cornelissen, Natalie Papazian, Tanja Konijn, Remco M. Hoogenboezem, Mathijs A. Sanders, Bart A. Westerman, Mehmet Gönültas, Jaap Kwekkeboom, Joke M. M. den Haan, Rogier M. Reijmers, Reina E. Mebius, Tom Cupedo	2017	33
16	Use of the gamma camera for early detection of osseous metastases from mammary cancer British journal of surgery ·C. S. B. Galasko, Bart A. Westerman, J Li, R A Sellwood, J I Burn	1968	29
17	CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [68Ga]Ga-Pentixafor /[177Lu]Lu-Pentixather European Journal of Nuclear Medicine and Molecular Imaging ·Sarah Jacobs, Pieter Wesseling, Bart de Keizer, Nelleke Tolboom, Tessa Ververs, Gerard C. Krijger, Bart A. Westerman, Tom J. Snijders, Pierre A. Robe, Anja G. van der Kolk	2021	26
18	To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology Anticancer Research ·Btissame El Hassouni, Giulia Mantini, Giovanna Li Petri, Mjriam Capula, Lenka N.C. Boyd, H Weinstein, Andrea Vallés‐Martí, Mathilde C.M. Kouwenhoven, Elisa Giovannetti, Bart A. Westerman, Godefridus J. Peters, (unknown)	2019	26
19	The cellular Pax–Hox–Helix connection Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Bart A. Westerman, Cornelis Murre, Cees B.M. Oudejans	2003	24
20	A genome-wide RNAi screen in mouse embryonic stem cells identifies Mp1 as a key mediator of differentiation The Journal of Experimental Medicine ·Bart A. Westerman, A. Koen Braat, Nicole Taub, Marko Potman, Joseph H.A. Vissers, Marleen Blom, Els Verhoeven, Hans Stoop, Ad Gillis, Arno Velds, Wouter Nijkamp, Roderick L. Beijersbergen, Lukas A. Huber, Leendert H. J. Looijenga, Maarten van Lohuizen	2011	24

About Bart A. Westerman

Bart A. Westerman is a scholar working on Molecular Biology, Genetics, Oncology, Surgery and Immunology, having authored 52 papers that have together received 1.3k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (12 papers), Epigenetics and DNA Methylation (9 papers), Prenatal Screening and Diagnostics (6 papers), Genetic Syndromes and Imprinting (5 papers), Neuroblastoma Research and Treatments (5 papers), Melanoma and MAPK Pathways (4 papers), Microtubule and mitosis dynamics (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Genetics (181 citations), Cancer Research (182 citations), Obstetrics and Gynecology (90 citations), Molecular Biology (769 citations) and Pediatrics, Perinatology and Child Health (174 citations). Bart A. Westerman has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Cees B.M. Oudejans, Georgi K. Kanev, Chris de Graaf, Albert J. Kooistra, Iwan J. P. de Esch, Inge J. van Wijk, Thomas Würdinger, Ankie Poutsma, Maarten van Lohuizen and Monique A. M. Mulders. Their work appears in journals such as Neuro-Oncology Advances, The International Journal of Biological Markers, Drug Resistance Updates, Genomics and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact